All posts by: Michael Zand

About Michael Zand

CRISPR Strategy & Standards: How Synthego’s Free Software Lays The Groundwork For CRISPR Futures – Bio-IT World

Continue reading

2018-03-21 NEWS

Bio-IT World

CRISPR Strategy & Standards: How Synthego’s Free Software Lays The Groundwork For CRISPR Futures
Bio-IT World
March 21, 2018 | “Science really moves forward when things become easier to the scientist: when you don’t have to spend as much time doing something, or a new capability comes on the scene,” says Paul Dabrowski, CEO and co-founder of Synthego. CRISPR

Continue reading

2018-03-21 NEWS

Times of Malta

Blood cancer survivor meets ‘genetic twin’ stem cell donor
Times of Malta
Peter Milburn and Aysha Lord at the charity’s Let’s Make a Spark Award ceremony, as the father of four who survived blood cancer has met and thanked the “genetic twin” stem cell donor who saved his life. A father of four who survived blood cancer has
Blood cancer survivor meets `genetic twin´ stem cell donorInfosurhoy

all 2 news articles »

Continue reading

2018-03-21 NEWS

PR Newswire (press release)

BioMarin’s Gene Therapy Manufacturing Facility Recognized with Industry Award
PR Newswire (press release)
SAN RAFAEL, Calif., March 21, 2018 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the International Society for Pharmaceutical Engineering (ISPE) selected the company’s gene therapy manufacturing facility as the 2018

and more »

Continue reading

2018-03-21 NEWS

Multiple Sclerosis News Today

Blood Stem Cell Transplants Improve RRMS Patients’ Disability, Phase 3 Trial Shows
Multiple Sclerosis News Today
Blood stem cell transplants lead to significant improvements in relapsing-remitting multiple sclerosis patients’ disability, a Phase 3 clinical trial shows. The 110 patients who took part in the MIST study (NCT00273364) were having relapses after

Continue reading

2018-03-21 NEWS

Multiple Sclerosis News Today

Blood Stem Cell Transplants Improve RRMS Patients’ Disability, Phase 3 Trial Shows
Multiple Sclerosis News Today
Blood stem cell transplants lead to significant improvements in relapsing-remitting multiple sclerosis patients’ disability, a Phase 3 clinical trial shows. The 110 patients who took part in the MIST study (NCT00273364) were having relapses after

Continue reading

2018-03-21 NEWS

OregonLive.com

PRP and stem cell: Can civilians now heal more like professional athletes?
OregonLive.com
“When platelets are around they recruit stem cells in the area to help re-build damaged tissue. In the knee, because there’s no flood flow in cartilage and there are very few stem cells resident in the knee joint, platelets will shut down inflammatory

Continue reading

2018-03-21 NEWS

OregonLive.com

PRP and stem cell: Can civilians now heal more like professional athletes?
OregonLive.com
“When platelets are around they recruit stem cells in the area to help re-build damaged tissue. In the knee, because there’s no flood flow in cartilage and there are very few stem cells resident in the knee joint, platelets will shut down inflammatory